Abstract
Pulmonary mucormycosis is a life-threatening opportunistic mycosis that can infect a wide range of hosts with immune defects, including patients with severe neutropenia, receiving corticosteroids or other immunosuppression. Unlike pulmonary aspergillosis, the prognosis of pulmonary mucormycosis has not improved significantly in the past decade, mainly due to the difficulty of early diagnosis and the limited activity of current antifungal drugs on mucormycosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Feng, J., Wu, B., Jiang, E., Li, W., Meng, C. (2020). Pulmonary Mucormycosis. In: Feng, J., Wu, B., Jiang, E., Li, W., Meng, C. (eds) Rapid On-Site Evaluation (ROSE) in Diagnostic Interventional Pulmonology. Springer, Singapore. https://doi.org/10.1007/978-981-15-5246-5_8
Download citation
DOI: https://doi.org/10.1007/978-981-15-5246-5_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-5245-8
Online ISBN: 978-981-15-5246-5
eBook Packages: MedicineMedicine (R0)